-
1
المؤلفون: Heather Shaw, Paul Nathan, Karla A. Lee, M. K. Luong, Tim D. Spector, Veronique Bataille
المصدر: British Journal of Cancer
مصطلحات موضوعية: Cancer microenvironment, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Review Article, Gut flora, 03 medical and health sciences, 0302 clinical medicine, Immune system, Neoplasms, Internal medicine, Tumor Microenvironment, medicine, Humans, Microbiome, Precision Medicine, Immune status, Bacteria, biology, business.industry, Probiotics, Cancer, Fecal Microbiota Transplantation, medicine.disease, biology.organism_classification, Gut microbiome, Immune checkpoint, Gastrointestinal Microbiome, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Diet Therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d168a332fe613d9eb0363e190439e568Test
https://doi.org/10.1038/s41416-021-01467-xTest -
2
المؤلفون: Richard Kaplan, Hanna Bryant, Mahesh K. B. Parmar, Paul Nathan, Martin R. Stockler, Ian D. Davis, James Larkin, David J. Harrison, Salena Mulhere, Bhavna Oza, Alison Fielding, Babak Choodari-Oskooei, Grant D. Stewart, Tim Eisen, Sarah Scovell, Nat Thorogood, Toni K. Choueiri, Anita McWhirter, Laurence Albiges, Brian I. Rini, Thomas Powles, Ben Smith, Eleni Frangou, Clare Shakeshaft, Alastair W. S. Ritchie, Axel Bex, Angela M. Meade
المساهمون: University of St Andrews. School of Medicine, University of St Andrews. Sir James Mackenzie Institute for Early Diagnosis, University of St Andrews. Cellular Medicine Division
المصدر: Contemporary clinical trials. 108
مصطلحات موضوعية: medicine.medical_specialty, RM, Locally advanced, Phase (combat), RC0254, SDG 3 - Good Health and Well-being, RAMPART, London, Medicine, Humans, Pharmacology (medical), Medical physics, Platform trial, Trial registration, License, Carcinoma, Renal Cell, Protocol (science), business.industry, RC0254 Neoplasms. Tumors. Oncology (including Cancer), General Medicine, Regulatory Submission, Kidney Neoplasms, RM Therapeutics. Pharmacology, Clinical trial, Renal cancer, MAMS, T-DAS, Durvalumab, business, Tremelimumab
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0194c3ee0d4a13bc0ec0088f3a6189b2Test
https://pubmed.ncbi.nlm.nih.gov/34538401Test -
3
المؤلفون: Paul Nathan, Michael Dougan, Chrystal M. Paulos, Silvia C. Formenti, Katie M. Campbell, Paolo A. Ascierto, Alessandro Morabito, Yana G. Najjar, Lisa H. Butterfield, John M. Timmerman, Filip Janku, Akash Patnaik, Samir N. Khleif, Leisha A. Emens, Bruno Daniele, Bradley I. Reinfeld, Heath D. Skinner, Tomas Kirchhoff, Igor Puzanov, Kunle Odunsi
المصدر: Journal of translational medicine, vol 19, iss 1
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-20 (2021)
Journal of Translational Medicineمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Immune checkpoint inhibitors, Immunology, lcsh:Medicine, Disease, Meeting Report, Medical Oncology, Clinical success, Medical and Health Sciences, General Biochemistry, Genetics and Molecular Biology, Vaccine Related, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, Biomarkers, Tumor, medicine, Humans, Combination therapy, Intensive care medicine, Melanoma, Cancer, Tumor, business.industry, lcsh:R, General Medicine, Immunotherapy, Immune checkpoint, Clinical trial, 030104 developmental biology, Good Health and Well Being, Italy, Tumor microenvironment, 030220 oncology & carcinogenesis, Immunization, business, Vaccine, Biomarkers, Checkpoint inhibitors
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a87c7662f5edb6843056f3a9723fcf2Test
https://escholarship.org/uc/item/2178563tTest -
4
المؤلفون: Tim Eisen, Bhavna Oza, Joaquim Bellmunt, Axel Bex, Janet E. Brown, Mahesh K. B. Parmar, Martin R. Stockler, Richard Kaplan, Barry W. Hancock, Ian D. Davis, Gregers G. Hermann, James Larkin, Steven Joniau, A.W.S. Ritchie, Jim Barber, Rhona McMenemin, Lisa Pickering, Angela M. Meade, Paul Nathan, Eleni Frangou, Elizabeth Hodgkinson, Bernard Escudier, Grant D. Stewart, Benjamin Smith, Laurence Albiges
المساهمون: Frangou, Eleni [0000-0002-5978-292X], Kaplan, Rick [0000-0002-0189-8348], Davis, Ian D [0000-0002-9066-8244], Larkin, James [0000-0001-5569-9523], Joniau, Steven [0000-0003-3195-9890], Hermann, Gregers G [0000-0002-8413-5919], Bellmunt, Joaquim [0000-0003-2328-3421], Stewart, Grant D [0000-0003-3188-9140], Parmar, Mahesh KB [0000-0003-0166-1700], Apollo - University of Cambridge Repository
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(34)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Sorafenib, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, urologic and male genital diseases, Disease-Free Survival, law.invention, Placebos, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Renal cell carcinoma, Risk Factors, Internal medicine, medicine, Carcinoma, Humans, Survival rate, neoplasms, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Chemotherapy, business.industry, Middle Aged, medicine.disease, female genital diseases and pregnancy complications, Kidney Neoplasms, Clinical trial, Survival Rate, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, Adjuvant, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7048e7916526f23d7c7a4d1385f9c71dTest
https://pubmed.ncbi.nlm.nih.gov/33874729Test -
5
مصطلحات موضوعية: Oncology, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Immune checkpoint inhibitors, medicine.medical_treatment, Medizin, Context (language use), Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Tumor Microenvironment, Humans, 030212 general & internal medicine, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Tumor microenvironment, business.industry, medicine.disease, Clinical trial, 030220 oncology & carcinogenesis, Immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1ca59ce0a443693aed8c8e11018ab9Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85092193946Test -
6
المؤلفون: Angus G. Dalgleish, Jonathan Cebon, Grant A. McArthur, Dennis Haack, Peter Hersey, Christian H. Ottensmeier, Michael Millward, Michael Findlay, Paul Nathan, Jeremy Marsden, P. Rod Dunbar, Cyril Fisher, Martin Gore, T.R. Jeffry Evans, Liliana Endo-Munoz, Ralph Venhaus, Andreas Behren, Weisan Chen, John F. Thompson, Margaret A. Brimble, Marples Maria, Ian D. Davis, Euan Walpole, Geoff Williams, Heather Jackson, Pippa Corrie, Mark Smithers, Candani Tutuka, Sintia Winkler, Duncan MacGregor, Vincenzo Cerundolo, Lloyd J. Old, Eugene Maraskovsky
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
JOURNAL FOR IMMUNOTHERAPY OF CANCERمصطلحات موضوعية: Male, Oncology, Cancer Research, Skin Neoplasms, Biopsy, medicine.medical_treatment, Dermatologic Surgical Procedures, Phases of clinical research, tumours, Immunogenicity, Vaccine, Clinical endpoint, Immunology and Allergy, Melanoma, RC254-282, Phospholipids, Skin, Clinical/Translational Cancer Immunotherapy, randomised trials, education.field_of_study, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, HLA, Drug Combinations, Cholesterol, Chemotherapy, Adjuvant, Molecular Medicine, Female, NY-ESO-1, Adjuvant, medicine.medical_specialty, Immunology, Population, Cancer Vaccines, Disease-Free Survival, Adjuvants, Immunologic, Double-Blind Method, Antigens, Neoplasm, Internal medicine, medicine, Humans, education, Neoplasm Staging, Pharmacology, Chemotherapy, business.industry, Membrane Proteins, Saponins, medicine.disease, Clinical trial, Neoplasm Recurrence, Local, business, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a718a8b256e0ccae28366eb0bd59a9Test
https://eprints.gla.ac.uk/214630/1/214630.pdfTest -
7
المؤلفون: Vijay Kasturi, Josh Reed, Sarah Flaskett, Elena Benincasa, Paolo A. Ascierto, Giovanni Grignani, Céleste Lebbé, Arne Engelsberg, Paul Nathan, John Walker, Rodrigo Ramella Munhoz, Subramanian Hariharan, Shahneen Sandhu, Eyal Fenig, Luc Dirix
المصدر: Journal for immunotherapy of cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, Antibodies, Monoclonal, Humanized, Avelumab, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, Immunology and Allergy, In patient, Objective response, RC254-282, Aged, Aged, 80 and over, Pharmacology, Chemotherapy, business.industry, Merkel cell carcinoma, Correction, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Carcinoma, Merkel Cell, Clinical trial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Expanded access, Molecular Medicine, Female, Human medicine, business, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04fa5cc67657a7f10de54a742d8d947Test
https://repository.uantwerpen.be/docstore/d:irua:3784Test -
8
المؤلفون: Eduard Gasal, Paul Nathan, Antoni Ribas, Neha Pakhle, Victoria Atkinson, Céleste Lebbé, Dirk Schadendorf, Mario Mandalà, Daniel Gusenleitner, Paolo A. Ascierto, Aisha Masood, Erika Richtig, Catarina D. Campbell, Reinhard Dummer, Ana Arance, Keith T. Flaherty, Hussein Abdul-Hassan Tawbi, Naoya Yamazaki, Georgina V. Long, Caroline Robert, Jan C. Brase
المساهمون: University of Zurich, Dummer, Reinhard
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Skin Neoplasms, Medizin, Cohort Studies, 0302 clinical medicine, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Oximes, Clinical endpoint, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Melanoma, Trametinib, MEK inhibitor, Imidazoles, 10177 Dermatology Clinic, General Medicine, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Biomarker (medicine), Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, Mutation, Missense, 610 Medicine & health, Genetics and Molecular Biology, Pyrimidinones, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Young Adult, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Biomarkers, Tumor, Humans, Protein Kinase Inhibitors, Aged, business.industry, Dabrafenib, medicine.disease, Clinical trial, Regimen, 030104 developmental biology, General Biochemistry, business
وصف الملف: 870_Dummer_R._et_al._Combined_PD-1,_BRAF_and_MEK_inhibition_in_advanced_BRAF-mutant_melanoma_Nature_Medicine_2020.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b17ee96d80a3281cdd7448c58c9110fTest
https://www.ncbi.nlm.nih.gov/pubmed/33020648Test -
9
المؤلفون: Naomi Chuchu, Paul Nathan, Manil Subesinghe, Seau Tak Cheung, Lavinia Ferrante di Ruffano, Abha Gulati, Clare Davenport, Lopa Patel, Sue Ann Chan, Kathie Godfrey, Jonathan J Deeks, Jacqueline Dinnes, Yemisi Takwoingi, Rubeta N Matin, Alana Durack, Hywel C Williams, Zoe Traill, Susan Bayliss
المصدر: Cochrane Database Syst Rev
2019, ' Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma ', The Cochrane database of systematic reviews, vol. 2019, no. 7, CD012806, pp. CD012806 . https://doi.org/10.1002/14651858.CD012806.pub2Testمصطلحات موضوعية: Adult, medicine.medical_specialty, Skin Neoplasms, Population, Whole body imaging, Sentinel lymph node, Sensitivity and Specificity, 03 medical and health sciences, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Adjuvant therapy, Medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Diagnosis, Computer-Assisted, Neoplasm Metastasis, education, Melanoma, Neoplasm Staging, Randomized Controlled Trials as Topic, Ultrasonography, PET-CT, education.field_of_study, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, Magnetic Resonance Imaging, Clinical trial, Positron emission tomography, Radiology, Neoplasm Recurrence, Local, business, Tomography, X-Ray Computed, 030217 neurology & neurosurgery
وصف الملف: PDF; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59e214996eb41ae22731e72eb8f7bd3Test
-
10
المؤلفون: Stéphane Oudard, Benoit Beuselinck, Victoria Neiman, Sabeen Mekan, Frede Donskov, Asim Amin, Philippe Barthélémy, Howard Gurney, David F. McDermott, Christian Kollmannsberger, M. Brent McHenry, Osvaldo Arén Frontera, Ignacio Duran, Camillo Porta, Paul Nathan, Elizabeth R. Plimack, Toni K. Choueiri, Daniel Y.C. Heng, Michael R. Harrison, Raya Leibowitz-Amit, David Pook, Robert J. Motzer, Nizar M. Tannir, Marc-Oliver Grimm, Yoshihiko Tomita, Pamela Salman, Saby George, Sjoukje F. Oosting, Sergio Bracarda, Thomas Powles, CheckMate Investigators, Bruce G. Redman, Viktor Grünwald, Bohuslav Melichar, Bernard Escudier, Hans J. Hammers, Michael A. Carducci, Scott S. Tykodi, Brian I. Rini
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Lancet Oncol
Lancet Oncology, 20(10), 1370-1385. ELSEVIER SCIENCE INC
Motzer, R J, Rini, B I, McDermott, D F, Arén Frontera, O, Hammers, H J, Carducci, M A, Salman, P, Escudier, B, Beuselinck, B, Amin, A, Porta, C, George, S, Neiman, V, Bracarda, S, Tykodi, S S, Barthélémy, P, Leibowitz-Amit, R, Plimack, E R, Oosting, S F, Redman, B, Melichar, B, Powles, T, Nathan, P, Oudard, S, Pook, D, Choueiri, T K, Donskov, F, Grimm, M O, Gurney, H, Heng, D Y C, Kollmannsberger, C K, Harrison, M R, Tomita, Y, Duran, I, Grünwald, V, McHenry, M B, Mekan, S, Tannir, N M & CheckMate 214 Investigators 2019, ' Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma : extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 20, no. 10, pp. 1370-1385 . https://doi.org/10.1016/S1470-2045Test(19)30413-9مصطلحات موضوعية: Oncology, medicine.medical_specialty, Population, Medizin, Ipilimumab, Antineoplastic Agents, Article, law.invention, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Sunitinib, Humans, Progression-free survival, Paresthesia, education, Survival rate, Carcinoma, Renal Cell, Fatigue, education.field_of_study, business.industry, Alanine Transaminase, Lipase, Kidney Neoplasms, Progression-Free Survival, Intention to Treat Analysis, Clinical trial, Survival Rate, Nivolumab, Amylases, Hypertension, business, medicine.drug, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cdd429cbc1f569513fceee7da60507dTest
https://pubmed.ncbi.nlm.nih.gov/33152309Test
